Epicutaneous tests (also called patch tests) show whether the patient has a contact allergy. To do this, the skin of the back is exposed to contact allergens via test chambers on adhesive tape for a few days, then the skin reaction is evaluated.
Search results 1 to 25 from a total of 171
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
1,2-Benzisothiazolin-3-on, Natriumsalz 0,1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04556.01.1 | 23.12.2021 | |
|
1,3-Diphenylguanidin 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04554.01.1 | 02.01.2018 | |
|
1,3,5-Tris(2-hydroxyethyl)-hexahydrotriazin (Grotan BK) 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04553.01.1 | 14.12.2016 | |
1,4-Butandioldiglycidylether 0,25%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04555.01.1 | 14.12.2022 | |
1,6-Hexandioldiglycidylether 0,25%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04674.01.1 | 14.12.2022 | |
|
2-(2-Aminoethoxy)ethanol (Diglykolamin) 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04673.01.1 | 14.12.2016 | |
2-Hydroxy-4-methoxy-benzophenon (Oxybenzon) 10%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.11813.01.1 | 23.12.2019 | |
2-Hydroxyethylmethacrylat (HEMA) 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04672.01.1 | 15.12.2022 | |
|
2-Mercaptobenzothiazol 2%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.03467.02.1 | 14.12.2016 | |
3-Aminophenol (m-Aminophenol) 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04670.01.1 | 02.01.2018 | |
4-Aminophenol (p-Aminophenol) 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04720.01.1 | 23.12.2021 | |
4-tert.-Butylcatechol 0,25%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04534.01.1 | 10.07.2023 | |
4-tert.-Butylphenol 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04666.01.1 | 15.12.2022 | |
4,4‘-Diaminodiphenylmethan 0,5%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04669.01.1 | 15.12.2022 | |
4,4‘-Dihydroxybiphenyl 0,1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04668.01.1 | 23.12.2021 | |
|
7-Ethylbicyclooxazolidin (Bioban CS 1246) 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04657.01.1 | 14.12.2016 | |
Abietinsäure 10%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04658.01.1 | 15.12.2022 | |
Adeps lanae 30%, Testsalbe |
SmartPractice Europe GmbH |
54a/87 | 11.05.1987 | |
alpha-Amylzimtaldehyd 1%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04660.01.1 | 22.12.2022 | |
alpha-Hexylzimtaldehyd 10%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04661.01.1 | 22.12.2022 | |
Amerchol L101 50%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.03468.01.1 | 02.12.2022 | |
Ammoniumpersulfat 2,5%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.04663.01.1 | 15.12.2022 | |
|
Ammoniumthioglycolat 1%, Testlösung |
SmartPractice Europe GmbH |
PEI.D.04664.01.1 | 14.12.2016 | |
Atropinsulfat 1%, Testlösung |
SmartPractice Europe GmbH |
PEI.D.04665.01.1 | 18.12.2020 | |
Bacitracin 20%, Testsalbe |
SmartPractice Europe GmbH |
PEI.D.03424.01.1 | 23.12.2019 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 25.04.2025
